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PRELIMINARY AND SHORT REPORT
STUDIES ON THE QUANTITY OF RADIATION REACHING THE GONADAL
AREAS DURING DERMATOLOGIC X-RAY THERAPY
. PRELIMINARY REPOET*
VIcToR H. WITTEN, M.D., MARION B. SULZRERGER, M.D. AND WILLIAM D. STEWART, M.D.
In June, 1956, reports on "The Biological Effects of Atomic Radiation" and the "Hazards
to Man of Nuclear and Allied Radiations" Were published by committees of the National
Academy of Sciences of the United States, and the Medical Research Council of Great
Britain, respectively. These reports expressed considerable concern about the possible
appearance of mutations in future generations as a result of the ionizing radiation being
received by the general population. An estimate was submitted of the amount of radiation
the population was receiving for medical purposes and particular attention was called to the
importance of keeping the total amount of radiation reaching the gonads at the lowest
possible level, without sacrificing good therapeutic and diagnostic technics.
Because of the tenor of these reports and the general increasing awareness of the poten-
tial hazards of ionizing radiation in a world in which there is every prospect of a steadily
increasing environmental radioactivity, there is an ever increasing fear of medical x-rays
on the part of patients and increasing reluctance to employ them in the therapy of se-
lected dermatoses. For these reasons we considered it not only important but imperative to
investigate the extent to which the gonads are exposed to x-rays when this valuable form of
therapy is administered in the treatment of common skin diseases.
These studies consisted of measuring the amount of radiation reaching the gonadal
areas of males and females during the routine x-ray therapy of various dermatologic condi-
tions. As outlined below the treatments were carried out according to generally accepted
technics, with the usual types and amounts of radiation and the usual methods of shielding.
EQUIPMENT
The source of radiation used in this study was a Picker Zephyr 120KV x-ray apparatus.
This unit has a circulating oil-cooled, glass window x-ray tube mounted in a metal housing.
The table on which the patients were treated was constructed of wood and very sturdy.
It was covered with an upholstered cushion about one inch thick. The metal enclosures for
the high voltage-generator equipment and the oil circulating pump were located under this
table. A standard, tubular steel upholstered office chair was used for seating patients who
were to have wrist, hands or fingers treated.
Keleket Model K-112 Dosimeters were used to measure radiation dose. These dosinieters
consisted of a permanently sealed, cylindrical plastic chamber. Each contained a borosili-
cate glass fiber electrometer, the movements of which could be read directly on a scale with
a range of 0—200 milliroentgens (mr). The leakage rate for these instruments is less than
2% of the full scale for a 24 hour period. A portable, battery-powered Keleket K-135 charg-
ing unit was used to recharge these dosimeters after exposure to irradiation.
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TABLE I
Range of dosimeter 2 to 125 125 to 200 3 to 196
readings in mr per
treatmentt
(Gonadal Dose)
* Filtered Radiation
t Treatment is used to mean the one or two exposures administered to a given area (i.e.
face, chest) at one sitting.
PROCEDURE
The patient receiving x-ray therapy was placed in a prone or a supine position on the
table, or was seated in an adjacent chair with the hand on the table. Shielding was done
according to conventional technics.
The machine was operated at 90 KV and 7 ma, which delivered radiation with a half
value layer (RVL) of 0.9 mm Al. For two patients, it was operated at 114 Ky, with 1 mm.
Al. added filtration, for which radiation the RYL was 2.1 mm Al. The target-skin distance
was 10 inches except where a cone was used, when it was 8.25 inches. The surface dose de-
livered to the skin area being treated ranged from 85 to 680 r.
Two dosimeters were used for each measurement. They were placed in the lap of the
patient whose wrist, hand or fingers were treated while in a sitting position. The dosimeters
were set upright, between the thighs and adjacent to the testes and scrotum in males treated
in prone or supine position, and under the hack just lateral to the lumbo-sacral articulation
in females treated in a supine position. (See figures, Table I) One female treated in the
prone position had the dosimeters placed beneath the abdomen at the level of the lumbo-
sacral articulation. The distance from the tube to dosimeters was carefully recorded in each
instance. The readings for the pair of dosimeters were averaged for each exposnre when any
difference between the two occurred.
RESULTS
This preliminary report covers 38 readings recorded on 16 patients. Of these, 20 readings
were on S patients treated in a horizontal position. The skin conditions treated in this group
were: acne vulgaris in 6, foot eczema in 1, and hydradenitis of the thighs in 1. Doses to the
gonadal areas from "stray" and scatter radiation in this group ranged from 2 mr to 125 mr
per treatment (85 r to 340 r). In one case, where three treatments were given at one sitting
Quantity of X-Radiation Measured at the Gonadal Area of Patients Treated in
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(1 to the face, 1 to the back and 1 to the chest, representing 510 r total) a total of 140 mr
was recorded at the gonadal area.
Two patients in the supine position each received 2 treatments with filtered radiation
having an HVL of 2.1 mm Al. The condition treated was hidradenitis suppurativa of the
axillae in one patient, and of the thighs in the other. Both treatments to the thighs (170 r
each), and one of the treatments to the axillae (340 r) each delivered a dose of more than
200 mr to the gonadal areas. When the axillae were irradiated at a subsequent sitting (total
340 r) the dose to the gonadal area was in the range of 125 mr. These patients were carefully
shielded and placed in position.
In the last group, there were 14 readings on 6 patients taken in the sitting position, with
hands or forearms being treated for psoriasis, nail changes, and verrucae. In 3 of these
patients, cones were used to limit the irradiated field. In the others, lead shielding was
placed around the irradiated area. In the patients irradiated without cones, but with con-
ventional shielding, the radiation to the gonadal area ranged from 50 mr to 158 mr (85 r to
170 r). In the patients treated with cones, the dose in the gonadal area varied from 3 mr to
196 mr (85 r to 510 r).
suIuruArnzINo niscussiox
It is not our purpose here to discuss the opinions as to the amount of gonadal radiation
that is considered to be acceptable and 'safe' according to genetic standards as published by
the National Academy of Sciences. No matter what may be considered "safe doses", it is
desirable to know how much radiation reaches the gonads of patients who receive routine
dermatologic x-ray therapy with conventional equipment (and how this may be reduced or
eliminated without reducing the efficacy of the therapy).
Many variables and unexpected factors that increased or decreased the doses to the
gonadal areas were discovered during these recordings, and the dose to the gonadal area is
not a predictable figure based on the roentgens delivered or the distance from the x-ray tube
to the gonadal area, although these are important factors. The variables are at present
under investigation in an additional series of studies on patients, and also on a pressedwood
phantom. Furthermore, efforts are being made to find the most effective means of elimi-
nating, or at least reducing to a minimum, the amount of radiation reaching the gonads,
without reducing the efficacy of the therapy. In this regard, factors under study include:
1) the most efficient types and methods of shielding, 2) the means for reducing secondary
radiation from the table and other equipment beneath and about the irradiated area, 3)
the positioning and tilt of the x-ray tube and methods of reducing the stray radiation from
the tube head, 4) the effects of the position of the upright metal supports and the arm sus-
pending the tube, and 5) the most effective placing of the patient to protect the gonads.*
Studies are also in progress to measure the amount of ionizing radiation received by the
ovary more accurately than is possible with the present estimates based on readings made
at the skin surface.
Meanwhile, as a result of these preliminary studies carried out in a practice limited to
dermatology, a few general recommendations may be made:
1. The possibility of gonadal exposure should be kept in mind by all practitioners utilizing
therapeutic or diagnostic ionizing radiation.
2. The distance from the x-ray tube to the gonadal area should be increased to the
maximum consistent with good therapeutic technic by proper placing of the patient
and by other means.
3. Shielding of the gonadal area should be utilized routinely in x-radiation therapy.
4. All medical x-ray apparatus, tables, etc. should be designed and constructed so as to
reduce to a minimum scatter radiation to the gonadal areas.
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* Since submitting this paper for publication our further studies have demonstrated that,
*ith care and relatively simple measures, it is generally possible to reduce by a substantial
amount the radiation dose reaching the gonads during routine dermatological therapy.
